JLHL vs LOTUSEYE: Stock Comparison

Jupiter Life Line Hospitals Limited vs Lotus Eye Hospital and Institute Limited

Live data: 15 July 2026, 4:08 PM IST • Source: NSE and company filings

Jupiter Life Line Hospitals Limited is the larger company by market capitalisation. Jupiter Life Line Hospitals Limited shows a lower P/E, a higher ROE and a higher dividend yield, while Lotus Eye Hospital and Institute Limited shows faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Side-by-side comparison of Jupiter Life Line Hospitals Limited and Lotus Eye Hospital and Institute Limited on live price, valuation, growth, profitability, leverage and quarterly shareholding. Highlighted values mark the more favourable of the two on that metric's usual reading; a single metric is never the full story.

On standard readings, JLHL is more favourable on 9 of 13 scored metrics and LOTUSEYE on 4These counts are context-free and are not an overall rating.

Key Differences

Market Cap
JLHL is the larger company
₹9,835 Cr vs ₹254 Cr
P/E Ratio
JLHL has a lower P/E
48.96x vs 3,332.5x
P/B Ratio
LOTUSEYE has a lower P/B
4.61x vs 6.31x
EPS
JLHL has higher earnings per share
₹29.59 vs ₹0.04
Dividend Yield
JLHL has a higher dividend yield
0.14% vs 0%
Revenue Growth (TTM YoY)
LOTUSEYE has faster revenue growth
18.2% vs 17.1%
EPS Growth (TTM YoY)
JLHL has faster EPS growth
12% vs 0%
Qtr Sales Growth
LOTUSEYE has stronger quarterly sales growth
18.2% vs 15.2%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricJLHLLOTUSEYE
SectorHealthcareHealthcare
IndustryHospitalHospital

Price

MetricJLHLLOTUSEYE
Live Price₹1,499.8₹120.11
Day Change1.1%-2.33%
Volume49,58330,781
52-Week High₹1,625₹147
52-Week Low₹1,178₹70.84
Distance from 52W High-7.7%-18.29%

Valuation

MetricJLHLLOTUSEYE
Market Cap₹9,835 Cr₹254 Cr
P/E Ratio48.96x3,332.5x
P/B Ratio6.31x4.61x
EPS₹29.59₹0.04
Book Value₹235.5₹28.23
Dividend Yield0.14%0%

Growth

MetricJLHLLOTUSEYE
Revenue Growth (TTM YoY)17.1%18.2%
EPS Growth (TTM YoY)12%0%
Qtr Sales Growth15.2%18.2%
Qtr Profit Growth8.66%-224%

Profitability & Leverage

MetricJLHLLOTUSEYE
ROE13.1%0.13%
ROCE14.8%1.16%
Net Margin13.01%0.15%
Operating Margin22.9%6.29%
Debt to Equity0x0x

Shareholding

As of Mar 2026 • change vs previous quarter
MetricJLHLLOTUSEYE
Promoter Holding40.91%37.39% 6.34 pp
FII Holding8.48%0% 0.01 pp
DII Holding17.01% 0.42 pp0.02%
Public Holding33.6% 0.43 pp59.84% 0.53 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Jupiter Life Line Hospitals Limited and Lotus Eye Hospital and Institute Limited.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.